ORPHA:519930
Fungal keratitis
Also known as: Keratomycosis · Mycotic keratitis
Publications
5,557
Trials
13
Interventional, condition-specific
Researchers
1,007
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare disorder of the anterior segment of the eye characterized by ocular infection by human-pathogenic fungi, most commonly Aspergillus, Candida, or Fusarium species, which gain access into the corneal stroma through a defect in the corneal epithelium. Risk factors include trauma, ocular surface disease, contact lenses, or immunocompromised state. Patients present with pain, foreign body sensation, redness, photophobia, tearing, secretion, or blurred vision. The condition may be complicated by corneal destruction and perforation, endophthalmitis, scleritis, and panophthalmitis.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0033821
- UMLS:C1262117
- NCIT:C128370
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
5,557 matched papers (3,413 in last 10 years) Source
- Phenotype characterisedNot found
No HPO disease–phenotype associations via Monarch for these Mondo IDs
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationPartial
1 EMA designation (none yet with FDA orphan-indication approval) — e.g. Polihexanide Source
- Interventional trialPresent
13 matched on ClinicalTrials.gov (2 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
1
Designation · no FDA orphan-indication approval yet
- EMA PolihexanideTreatment of fungal keratitis · 21/08/2024 · PositiveEMA designation
Sources: FDA OOPD · EMA orphan designations
Open Targets candidates
15
Drugs / clinical candidates · MONDO_0033821
- AMPHOTERICIN B·phase 3
- CHLORHEXIDINE GLUCONATE·phase 3
- CYCLOSPORINE·phase 3
- MOXIFLOXACIN·phase 3
- NATAMYCIN·phase 3
- ROSE BENGAL FREE ACID·phase 3
- VORICONAZOLE·phase 3
- POVIDONE-IODINE·phase 2
- CEFTAZIDIME·unknown
- FLUCONAZOLE·unknown
- GENTAMICIN·unknown
- ITRACONAZOLE·unknown
- LEVOFLOXACIN·unknown
- RIBOFLAVIN·phase 1 2
- VANCOMYCIN·unknown
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
5,557
5,557 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
5,557 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
3,413 in the last 10 years · low confidence
Phrase hits: 5,557 · MeSH hits: 0
Who's working on it?
1,007
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Lin J13 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, NO.16 Jiangsu Road, Qingdao, Shandong Province, 266003, China. Electronic address: linjing_yk@126.com.
Papers in Europe PMC - 02Zhang L13 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province, China.
Papers in Europe PMC - 03Wang Q12 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, NO.16 Jiangsu Road, Qingdao, Shandong Province, 266003, China. Electronic address: yankewangqian@126.com.
Papers in Europe PMC - 04Zhao G12 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, NO.16 Jiangsu Road, Qingdao, Shandong Province, 266003, China. Electronic address: zhaoguiqiu_good@126.com.
Papers in Europe PMC - 05Li C11 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, NO.16 Jiangsu Road, Qingdao, Shandong Province, 266003, China. Electronic address: yankelicui@126.com.
Papers in Europe PMC - 06Das S8 papers · 2026
Cornea and Anterior Segment, Shantilal Shanghvi Cornea Institute, L V Prasad Eye Institute, Bhubaneswar, Odisha, India.
Papers in Europe PMC - 07Li Y8 papers · 2026
School of Pharmacy, Lanzhou University, Lanzhou, 730000, China.
Papers in Europe PMC - 08Wang Z8 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province, 266003, China.
Papers in Europe PMC - 09Sharma S7 papers · 2026
Department of Quality Assurance, ISF College of Pharmacy, Moga, 142001, Punjab, India.
Papers in Europe PMC - 10Chi M6 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province, 266003, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
13
interventional trials for this specific condition
13 interventional trials matched this specific condition name; 2 currently recruiting in our sample. 100 trials are registered for keratitis, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
13 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 93.5th percentile).
low confidence · 93.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
13 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06658002·RECRUITING·Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
Not reviewed·Conditions: Fungal Keratitis · Corneal Ulcer·Matched via name phrase
- NCT06463678·NOT YET RECRUITING·Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis
Not reviewed·Conditions: Fungal Keratitis·Matched via name phrase
Broader category: keratitis
100
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06975748·RECRUITING·A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis
Not reviewed·Conditions: Neurotrophic Keratitis·Matched via name phrase
- NCT07308938·NOT YET RECRUITING·Fluorometholone Study
Not reviewed·Conditions: Keratitis Bacterial · Corneal Ulcer (Diagnosis)·Matched via name phrase
- NCT07329686·RECRUITING·Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.
Not reviewed·Conditions: Herpes Simplex Keratitis · Corneal Neovascularization·Matched via name phrase
- NCT06964269·RECRUITING·Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease
Not reviewed·Conditions: Autoimmune Diseases · Dry Eye · Neurotrophic Keratitis·Matched via name phrase
- NCT07568730·RECRUITING·A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis
Not reviewed·Conditions: Neurotrophic Keratitis·Matched via name phrase
- NCT06451172·RECRUITING·Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
Not reviewed·Conditions: Bacterial Keratitis · Antibiotic-resistant Bacteria · Infections, Bacterial · Corneal Diseases·Matched via name phrase
- NCT07452588·NOT YET RECRUITING·Effect of Sodium Chloride 5% Solution as an Adjuvant Treatment With Antimicrobial Therapy in the Treatment of Bacterial Infectious Keratitis
Not reviewed·Conditions: Infectious Keratitis · Adjuvant Treatment Bacterial Infectious Keratitis · Sodium Chloride 5% Solution·Matched via name phrase
- NCT06999733·RECRUITING·A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis
Not reviewed·Conditions: Neurotrophic Keratitis·Matched via name phrase
- NCT07073729·NOT YET RECRUITING·Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study
Not reviewed·Conditions: Neurotrophic Keratitis·Matched via name phrase
- NCT05927428·RECRUITING·Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis
Not reviewed·Conditions: Neurotrophic Keratitis·Matched via name phrase
- NCT06474442·RECRUITING·A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis
Not reviewed·Conditions: Herpes Simplex Virus Type I Stromal Keratitis·Matched via name phrase
- NCT07394257·RECRUITING·Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis
Not reviewed·Conditions: Bacterial Keratitis · Recalcitrant Infectious Keratitis · Corneal Ulcer·Matched via name phrase
- NCT06213649·RECRUITING·Parasitic Ulcer Treatment Trial
Not reviewed·Conditions: Acanthamoeba Keratitis·Matched via name phrase
- NCT03918408·RECRUITING·Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
Not reviewed·Conditions: Keratoconus, Unstable · Bacterial Keratitis · Ectasia of Cornea·Matched via name phrase
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 14 · after dedupe 13 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 13 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (13)
- isrctn·ISRCTN16314965·No longer recruiting·A study of JNJ-95475939 in the treatment of participants with moderate to severe atopic dermatitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN56110442·No longer recruiting·Clinical investigation of soft contact lenses
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15020073·No longer recruiting·Exploring the benefits of grape pomace supplements for diabetic eye health: new clinical trial results
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN25958282·Recruiting·A trial using a new type of scan to detect myeloma
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN77975669·No longer recruiting·Comparing a comprehensive package of primary care to the standard of care to reduce blindness caused by severe corneal infections in Uganda
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17422545·No longer recruiting·‘iCam’ polymerase chain reaction (PCR) testing for rapid diagnosis of eye infections
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN87195453·No longer recruiting·A comparison of two treatment regimes for the treatment of fungal eye infections in East Africa
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14332621·No longer recruiting·Chlorhexidine 0.2% vs natamycin 5% for the treatment of fungal corneal infections
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15464650·No longer recruiting·Efficacy and safety of Hydrocortison-POS N1% and 2.5% versus Ficortril 0.5% in the treatment of acute inflammation of the ocular surface or adnexa for which steroid treatment is indicated
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN57259399·No longer recruiting·Comparing the effectiveness of topical voriconazole versus injection of voriconazole and atamycin for recalcitrant fungal keratitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN66216819·No longer recruiting·OCTOME study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN84613089·No longer recruiting·Intracameral voriconazole injection in the treatment of fungal endophthalmitis developed from keratitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN71482124·No longer recruiting·Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: a double-blinded, randomised clinical trial
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Fungal keratitis — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Fungal keratitis" OR "Keratomycosis" OR "Mycotic keratitis"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Fungal keratitis" OR "Keratomycosis" OR "Mycotic keratitis"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 13 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"keratitis"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (5557) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T18:01:12.104Z
